Patient-maintained sedation for oral surgery using a target-controlled infusion of propofol - a pilot study

OBJECTIVE: To assess the safety and efficacy of a new patient-maintained propofol system for conscious sedation in dentistry. DESIGN: Prospective clinical trial SETTING: Department of Sedation, Glasgow Dental Hospital and School, 2001 SUBJECTS AND METHODS: Patients scheduled for oral surgery with conscious sedation. Exclusions included ASA IV -V, inability to use the handset, opioid use and severe respiratory disease. INTERVENTIONS: Patients were given intravenous propofol to a level of 1.0 microg/ml (reducing from 1.5 microg/ml) using a target controlled infusion system, they then controlled their sedation level by double-clicking a handset which on each activation increased the propofol concentration by 0.2 microg/ml. MAIN OUTCOME MEASURES: Oxygen saturation, patient satisfaction, and surgeon satisfaction. RESULTS: Twenty patients were recruited, 16 female and four male. Nineteen patients completed sedation and treatment successfully. Mean lowest oxygen saturation was 94%. No patients were over-sedated. All patients successfully used the system to maintain a level of sedation adequate for their comfort. Patient and surgeon satisfaction were consistently high. CONCLUSIONS: Initial experience with this novel system has confirmed safety, patient satisfaction and surgeon satisfaction

Effects of flow rates and composition of the filter, and decay/ingrowth correction factors involved with the determination of in situ particulate \u3csup\u3e210\u3c/sup\u3ePo and \u3csup\u3e210\u3c/sup\u3ePb in seawater

Accurate measurements of particulate 210Po (210Pop) and 210Pb (210Pbp) are required in the investigation of (i) partitioning of Po and Pb between particulate and dissolved phases and (ii) export estimates of carbon and other key trace metals from the euphotic zone via sinking particulate matter. Based on the intercomparison of different composition of the filter material (QMA, Supor, Millipore, and Pall GN6) and flow rates (2 to 8 L min), we show how these factors affect the measured concentrations of 210Pop and 210Pbp and their activity ratios (AR). As such, we recommend using Supor 0.4 μm filter and a flow rate of up to 8 L/min for the measurements of210Pop and 210Pbp. Furthermore, we inter-compared 210Pop and 210Pbp obtained by small-volume McLane and large-volume MULVFS pumps. The activities of 210Pop in MULVFS filter samples are somewhat higher than that of McLane filter samples, whereas the 210Pop/210Pb AR collected by McLane pump is distinctly lower, suggesting some fractionation in the collection process by the pumping systems. Likewise comparison of vertical profiles of 210Pop and 210Pbp obtained using McLane pumps by two independent research groups at the two intercalibration stations in the Pacific Ocean show quite similar values except in the mesopelagic waters, suggesting possible uneven loading and presence of larger gelatinous plankton in the filter. Finally, we append a detailed analysis of various correction factors for the accurate calculation of in situ 210Po and 210Pb. Presented results are relevant to the worldwide community that uses 210Po-210Pb as tracers in aquatic systems

Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism

BACKGROUND: Long‐term medical management of hypersomatotropism (HS) in cats has proved unrewarding. Pasireotide, a novel somatostatin analogue, decreases serum insulin‐like growth factor 1 (IGF‐1) and improves insulin sensitivity in cats with HS when administered as a short‐acting preparation. OBJECTIVES: Assess once‐monthly administration of long‐acting pasireotide (pasireotide LAR) for treatment of cats with HS. ANIMALS: Fourteen cats with HS, diagnosed based on diabetes mellitus, pituitary enlargement, and serum IGF‐1 > 1000 ng/mL. METHODS: Uncontrolled, prospective cohort study. Cats received pasireotide LAR (6–8 mg/kg SC) once monthly for 6 months. Fructosamine and IGF‐1 concentrations, and 12‐hour blood glucose curves (BGCs) were assessed at baseline and then monthly. Product of fructosamine concentration and insulin dose was calculated as an indicator of insulin resistance (Insulin Resistance Index). Linear mixed‐effects modeling assessed for significant change in fructosamine, IGF‐1, mean blood glucose (MBG) of BGCs, insulin dose (U/kg) and Insulin Resistance Index. RESULTS: Eight cats completed the trial. Three cats entered diabetic remission. Median IGF‐1 (baseline: 1962 ng/mL [range 1051–2000 ng/mL]; month 6: 1253 ng/mL [524–1987 ng/mL]; P < .001) and median Insulin Resistance Index (baseline: 812 μmolU/L kg [173–3565 μmolU/L kg]; month 6: 135 μmolU/L kg [0–443 μmolU/L kg]; P = .001) decreased significantly. No significant change was found in mean fructosamine (baseline: 494 ± 127 μmol/L; month 6: 319 ± 113.3 μmol/L; P = .07) or MBG (baseline: 347.7 ± 111.0 mg/dL; month 6: 319.5 ± 113.3 mg/dL; P = .11), despite a significant decrease in median insulin dose (baseline: 1.5 [0.4–5.2] U/kg; 6 months: 0.3 [0.0–1.4] U/kg; P < .001). Adverse events included diarrhea (n = 11), hypoglycemia (n = 5), and worsening polyphagia (n = 2). CONCLUSIONS AND CLINICAL IMPORTANCE: Pasireotide LAR is the first drug to show potential as a long‐term management option for cats with HS

Crab cavities for linear colliders

Crab cavities have been proposed for a wide number of accelerators and interest in crab cavities has recently increased after the successful operation of a pair of crab cavities in KEK-B. In particular crab cavities are required for both the ILC and CLIC linear colliders for bunch alignment. Consideration of bunch structure and size constraints favour a 3.9 GHz superconducting, multi-cell cavity as the solution for ILC, whilst bunch structure and beam-loading considerations suggest an X-band copper travelling wave structure for CLIC. These two cavity solutions are very different in design but share complex design issues. Phase stabilisation, beam loading, wakefields and mode damping are fundamental issues for these crab cavities. Requirements and potential design solutions will be discussed for both colliders.Comment: 3 pages. To be published in proceedings of LINAC 2008, Victoria, Canad

Tris[2-(propyl­imino­meth­yl)phenolato-κ2 N,O]cobalt(III)

The title compound, [Co(C10H12NO)3], was synthesized from cobalt(III) fluoride and 2-(propyl­imino­meth­yl)phenol in refluxing methanol. The CoIII ion is hexa­coordinated by three N and three O atoms from three bidentate Schiff base ligands in an octa­hedral geometry

ROSAT X-ray sources in the field of the LMC I.Total LMC gas from the background AGN spectral fits

We analyzed a sample of 26 background X-ray sources in a ~60 square degree field of the Large Magellanic Cloud observed with the ROSAT PSPC. The sample has been selected from previously classified and optically identified X-ray sources. In addition pointlike and spectrally hard sources with at least 100 to 200 observed counts have been used for the analysis. We performed X-ray spectral fitting and derived total hydrogen absorbing column densities due to LMC gas in the range 10^20 - 2. 10^21 cm^-2. We compared these columns with the HI columns derived from a 21-cm Parkes survey of the LMC. For 7 optically identified sources we find, within the uncertainties derived from the X-ray spectral fit, agreement for both columns. For further 19 sources we constrain the LMC columns from the X-ray spectral fit assuming that the powerlaw photon index is that of AGN type spectra. We derive for 20 sources gas columns which are within the uncertainties in agreement with the HI columns. We derive for two background sources (RX J0536.9-6913 and RX J0547.0-7040) hydrogen absorbing column densities due to LMC gas, which are in excess to the HI columns. These sources - located in regions of large (~3. 10^21 cm^-2) LMC HI column densities - could be seen through additional gas which may be warm and diffuse, cold or molecular. For 10 sources we derive upper limits for the gas columns additional to HI and constrain the molecular mass fraction to <(30-140)%.Comment: Accepted by A&

Ruling out four-neutrino oscillation interpretations of the LSND anomaly?

Prompted by recent solar and atmospheric data, we re-analyze the four-neutrino description of current global neutrino oscillation data, including the LSND evidence for oscillations. The higher degree of rejection for non-active solar and atmospheric oscillation solutions implied by the SNO neutral current result as well as by the latest 1489-day Super-K atmospheric neutrino data allows us to rule out (2+2) oscillation schemes proposed to reconcile LSND with the rest of current neutrino oscillation data. Using an improved goodness of fit (gof) method especially sensitive to the combination of data sets we obtain a gof of only 1.6 times 10^{-6} for (2+2) schemes. Further, we re-evaluate the status of (3+1) oscillations using two different analyses of the LSND data sample. We find that also (3+1) schemes are strongly disfavoured by the data. Depending on the LSND analysis we obtain a gof of 5.6 times 10^{-3} or 7.6 times 10^{-5}. This leads to the conclusion that all four-neutrino descriptions of the LSND anomaly, both in (2+2) as well as (3+1) realizations, are highly disfavoured. Our analysis brings the LSND hint to a more puzzling status.Comment: 21 pages, 7 figure

Statistical Analysis of Different Muon-antineutrino->Electron-antineutrino Searches

A combined statistical analysis of the experimental results of the LSND and KARMEN \numubnueb oscillation search is presented. LSND has evidence for neutrino oscillations that is not confirmed by the KARMEN experiment. This joint analysis is based on the final likelihood results for both data sets. A frequentist approach is applied to deduce confidence regions. At a combined confidence level of 36%, there is no area of oscillation parameters compatible with both experiments. For the complementary confidence of 1-0.36=64%, there are two well defined regions of oscillation parameters (sin^2(2th),Dm^2) compatible with both experiments.Comment: 25 pages, including 10 figures, submitted to Phys. Rev.

The iron KαK_\alpha lines as a tool for magnetic field estimations in non-flat accretion flows

Observations of AGNs and microquasars by ASCA, RXTE, Chandra and XMM-Newton indicate the existence of broad X-ray emission lines of ionized heavy elements in their spectra. Such spectral lines were discovered also in X-ray spectra of neutron stars and X-ray afterglows of GRBs. Recently, Zakharov et al. (MNRAS, 2003, 342, 1325) described a procedure to estimate an upper limit of the magnetic fields in regions from which X-ray photons are emitted. The authors simulated typical profiles of the iron $K_\alpha$ line in the presence of magnetic field and compared them with observational data in the framework of the widely accepted accretion disk model. Here we further consider typical Zeeman splitting in the framework of a model of non-flat accretion flows, which is a generalization of previous consideration into non-equatorial plane motion of particles emitting X-ray photons. Using perspective facilities of space borne instruments (e.g. Constellation-X mission) a better resolution of the blue peak structure of iron $K_\alpha$ line will allow to evaluate the magnetic fields with higher accuracy.Comment: 22 pages, 6 figure